Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
andrea.pierangelini@cmd.ox.ac.uk

Research groups

Mass Spectrometry for Drug Target Discovery

Andrea Pierangelini

Postdoctoral Researcher

Recent publications

Molecular basis for CSB stimulation of the SNM1A DNA repair nuclease.

Roddan R. et al, (2025)

Interdomain Interactions Modulate Refolding Kinetics and Aggregation in a Monoclonal Antibody.

Trolese P. et al, (2025), J Am Soc Mass Spectrom, 36, 2405 - 2413

Driving Therapeutic Innovation in Neurodegenerative Disease With Hydrogen Deuterium eXchange Mass Spectrometry.

Pierangelini A. et al, (2025), Mol Cell Proteomics, 24

The main protease (Mpro) from SARS-CoV-2 triggers plasma clotting in vitro by activating coagulation factors VII and FXII.

Pagotto A. et al, (2025), Commun Biol, 8

DOPAC as a modulator of α-Synuclein and E46K interactions with membrane: Insights into binding dynamics.

Rizzotto E. et al, (2025), Int J Biol Macromol, 294

More publications